Literature DB >> 15303416

Treating chronic pain in the presence of substance abuse.

Ava H Stanley1, Monika M Safford.   

Abstract

Substance abuse and chronic pain are both debilitating illnesses. It is difficult to treat these disorders when they co-occur. We discuss such a case in the context of relevant literature and make recommendations for assessment, management, and documentation.

Entities:  

Mesh：

Year:  2004        PMID： 15303416      PMCID： PMC2568472     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  10 in total

1.  Primary care and addiction treatment: lessons learned from building bridges across traditions.

Authors:  A H Stanley
Journal:  J Addict Dis       Date:  1999

Review 2.  Brief interventions with substance-abusing patients.

Authors:  H N Barnes; J H Samet
Journal:  Med Clin North Am       Date:  1997-07       Impact factor: 5.456

Review 3.  Screening for alcohol and drug abuse.

Authors:  J B Schorling; D Buchsbaum
Journal:  Med Clin North Am       Date:  1997-07       Impact factor: 5.456

4.  Abuse liability in opioid therapy for pain treatment in patients with an addiction history.

Authors:  Michael Weaver; Sidney Schnoll
Journal:  Clin J Pain       Date:  2002 Jul-Aug       Impact factor: 3.442

5.  Medical disorders in a cohort of New York city drug abusers: much more than HIV disease.

Authors:  L S Brown; M J Hickson; D C Ajuluchukwu; J Bailey
Journal:  J Addict Dis       Date:  1993

Review 6.  Addiction: part II. Identification and management of the drug-seeking patient.

Authors:  L P Longo; T Parran; B Johnson; W Kinsey
Journal:  Am Fam Physician       Date:  2000-04-15       Impact factor: 3.292

7.  Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine.

Authors:  Cyril Rivat; Jean-Paul Laulin; Jean-Benoît Corcuff; Evelyne Célèrier; Laure Pain; Guy Simonnet
Journal:  Anesthesiology       Date:  2002-02       Impact factor: 7.892

8.  Fear and anxiety: divergent effects on human pain thresholds.

Authors:  J L Rhudy; M W Meagher
Journal:  Pain       Date:  2000-01       Impact factor: 6.961

Review 9.  Addiction and pain.

Authors:  Sidney H Schnoll; Michael F Weaver
Journal:  Am J Addict       Date:  2003

10.  Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal.

Authors:  Martin S Angst; Wolfgang Koppert; Ilka Pahl; David J Clark; Martin Schmelz
Journal:  Pain       Date:  2003-11       Impact factor: 6.961
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.